Cardiovascular and noncardiovascular mortality among patients starting dialysis.

CONTEXT Cardiovascular mortality is considered the main cause of death in patients receiving dialysis and is 10 to 20 times higher in such patients than in the general population. OBJECTIVE To evaluate if high overall mortality in patients starting dialysis is a consequence of increased cardiovascular mortality risk only or whether noncardiovascular mortality is equally increased. DESIGN, SETTING, AND PATIENTS Using data from between January 1, 1994, and January 1, 2007, age-stratified mortality in a European cohort of adults starting dialysis and receiving follow-up for a mean of 1.8 (SD, 1.1) years (European Renal Association-European Dialysis and Transplant Association [ERA-EDTA] Registry [N = 123,407]) was compared with the European general population (Eurostat). MAIN OUTCOME MEASURES Cause of death was recorded by ERA-EDTA codes in patients and matching International Statistical Classification of Diseases, 10th Revision codes in the general population. Standardized cardiovascular and noncardiovascular mortality rates, their ratio, difference, and relative excess of cardiovascular over noncardiovascular mortality were calculated. RESULTS Overall all-cause mortality rates in patients and the general population were 192 per 1000 person-years (95% confidence interval [CI], 190-193) and 12.055 per 1000 person-years (95% CI, 12.05-12.06), respectively. Cause of death was known for 90% of the patients and 99% of the general population. In patients, 16,654 deaths (39%) were cardiovascular and 21,654 (51%) were noncardiovascular. In the general population, 7,041,747 deaths (40%) were cardiovascular and 10,183,322 (58%) were noncardiovascular. Cardiovascular and noncardiovascular mortality rates in patients were respectively 38.1 per 1000 person-years (95% CI, 37.2-39.0) and 50.1 per 1000 person-years (95% CI, 48.9-51.2) higher than in the general population. On a relative scale, standardized cardiovascular and noncardiovascular mortality were respectively 8.8 (95% CI, 8.6-9.0) and 8.1 (95% CI, 7.9-8.3) times higher than in the general population. The ratio of these rates, ie, relative excess of cardiovascular over noncardiovascular mortality in patients starting dialysis compared with the general population, was 1.09 (95% CI, 1.06-1.12). Relative excess in a sensitivity analysis in which unknown/missing causes of death were regarded either as noncardiovascular or cardiovascular varied between 0.90 (95% CI, 0.88-0.93) and 1.39 (95% CI, 1.35-1.43). CONCLUSION Patients starting dialysis have a generally increased risk of death that is not specifically caused by excess cardiovascular mortality.

[1]  K. D. Workgroup K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  Y. Yuzawa,et al.  Aspects of immune dysfunction in end-stage renal disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[3]  R. Foley,et al.  Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  J. Sowers,et al.  Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. , 2006, Advances in chronic kidney disease.

[5]  Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  W. Bloembergen,et al.  Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. , 2001, Journal of the American Society of Nephrology : JASN.

[7]  M. Margaglione,et al.  Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study. , 2009, Atherosclerosis.

[8]  A. Collins,et al.  Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. , 1998, The New England journal of medicine.

[9]  M. Rocco,et al.  Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. , 2000, Kidney international.

[10]  A. Garg,et al.  Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. , 2002, Kidney international.

[11]  R Cornet,et al.  Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  R. Foley Infections and cardiovascular disease in patients with chronic kidney disease. , 2006, Advances in chronic kidney disease.

[13]  N. Kutner,et al.  Significance of frailty among dialysis patients. , 2007, Journal of the American Society of Nephrology : JASN.

[14]  P. Boyle,et al.  Cancer in patients on dialysis for end-stage renal disease: an international collaborative study , 1999, The Lancet.

[15]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  T. Stompór An Overview of the Pathophysiology of Vascular Calcification in Chronic Kidney Disease , 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[17]  L. Fitzpatrick,et al.  Vascular calcification. , 1999, Current opinion in nephrology and hypertension.

[18]  F. Dekker,et al.  Association of serum fetuin-A levels with mortality in dialysis patients. , 2007, Kidney international.

[19]  C. Zoccali,et al.  Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  R. Écochard,et al.  Effect of age, gender, and diabetes on excess death in end-stage renal failure. , 2007, Journal of the American Society of Nephrology : JASN.

[21]  R. Foley,et al.  Epidemiology of cardiovascular disease in chronic renal disease , 2000 .

[22]  Deeb N Salem,et al.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. , 2004, Journal of the American Society of Nephrology : JASN.

[23]  F. Dekker,et al.  The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  C. Wanner,et al.  Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  M. Ketteler,et al.  Novel insights into vascular calcification. , 2006, Kidney international. Supplement.

[26]  R. Wolfe,et al.  Causes of death in dialysis patients: racial and gender differences. , 1994, Journal of the American Society of Nephrology : JASN.

[27]  David C. Murray,et al.  Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. , 1995, Kidney international.

[28]  Charles E. McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[29]  T. Ekström,et al.  Impact of inflammation on epigenetic DNA methylation – a novel risk factor for cardiovascular disease? , 2007, Journal of internal medicine.

[30]  F. Dekker,et al.  The European Registry: Where do We Stand? , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[31]  J. Vandenbroucke,et al.  Serum troponin T concentration as a predictor of mortality in hemodialysis and peritoneal dialysis patients. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  F. Dekker,et al.  Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  Robert M Califf,et al.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.

[34]  B. Scribner,et al.  Accelerated atherosclerosis in prolonged maintenance hemodialysis. , 1974, The New England journal of medicine.

[35]  M. Rocco,et al.  Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. , 2004, Kidney international.